risperidone has been researched along with Emesis, Postoperative in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jabaley, CS | 1 |
| Gray, DW | 1 |
| Budhrani, GS | 1 |
| Lynde, GC | 1 |
| Adamopoulos, P | 1 |
| Easton, GS | 1 |
| O'Reilly-Shah, VN | 1 |
1 other study available for risperidone and Emesis, Postoperative
| Article | Year |
|---|---|
Chronic Atypical Antipsychotic Use Is Associated With Reduced Need for Postoperative Nausea and Vomiting Rescue in the Postanesthesia Care Unit: A Propensity-Matched Retrospective Observational Study.
Topics: Adult; Aged; Anesthesia Recovery Period; Antiemetics; Antipsychotic Agents; Aripiprazole; Drug Admin | 2020 |